Medium and high tumor FGFR1 mRNA expression was reported in 27–60% of patients with Sq-NSCLC (4, 19, 26), and 55 of 118 (47%) Sq-NSCLC tumors had FGFR1–3 mRNA overexpression (55, 56). This evidence concerns the gene FGFR1 and neoplasm.